(Q34996909)

English

Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

Jean-Luc Dubois-Randé

8

object named as

Jean-Luc Dubois-Randé

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

9

object named as

Serge Adnot

0 references

author name string

Pierre-François Lesault

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Laurent Boyer

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Gabriel Pelle

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ala Covali-Noroc

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Dominique Rideau

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Servais Akakpo

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Emmanuel Teiger

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

844-851

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Endothelial dysfunction and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Endothelium-derived contracting factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099371

8 July 2018

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03858.X

21 January 2018

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03858.X

21 January 2018

Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03858.X

21 January 2018

Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03858.X

21 January 2018

Antithrombotic properties of the thromboxane A2/prostaglandin H2 receptor antagonist S18886 on prevention of platelet-dependent cyclic flow reductions in dogs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03858.X

21 January 2018

Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03858.X

21 January 2018

The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03858.X

21 January 2018

Preclinical evaluation of S18886 in an experimental model of coronary arterial thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21564160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molsidomine improves flow-dependent vasodilation in brachial arteries of patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21564160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21564160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/21564160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2010.03858.X

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34996909&oldid=1565658784"